袖状胃切除术联合双通道术(sleeve gastrectomy with transit bipartition,SG-TB)作为一种新型的减重代谢手术,在减轻体重、改善糖尿病和其他代谢性疾病方面的有效性和安全性得到了初步认可,并且在临床应用中显示出了巨大的前景.然而SG-TB也面临着一些问题和挑战,如总病例数少、临床循证证据不足、吻合口及共同通道设计、胆汁反流、胃食管反流病、营养不良等.目前,仍需要进一步加强相关的研究工作,从而完善SG-TB的标准化操作,以期为进一步推广该手术方式提供参考依据.
Prospects and considerations of sleeve gastrectomy with transit bipartition
Sleeve gastrectomy with transit bipartition(SG-TB)was a novel bariatric and metabolic surgery that had received preliminary approval for its effectiveness and safety in reducing weight,improving diabetes,and other metabolic diseases.It showed promising prospects in clinical applications.However,SG-TB also faced some challenges including a small number of cases,insufficient clinical evidence,issues with anastomotic stoma and common channel design,bile reflux,gastroesophageal reflux disease,and malnutrition.Further research is needed to enhance the standardization of SG-TB procedures and provides reference for its wider implementation.
obesitytype 2 diabetes mellitusmetabolic and bariatric surgerysleeve gastrectomytransit bipartition